Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYVERSA THERAPEUTICS INC

0.6208
+0.00180.29%
Volume:142.38K
Turnover:87.87K
Market Cap:2.25M
PE:-0.07
High:0.6324
Open:0.6300
Low:0.6032
Close:0.6190
Loading ...
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 23, 2023

Major Issues Report

Form 8-K - Current report
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Dec 06, 2023

Correspondence

Form CORRESP - Correspondence
Dec 06, 2023

Correspondence

Form CORRESP - Correspondence
Dec 06, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 05, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 22, 2023

Correspondence

Form CORRESP - Correspondence
Nov 22, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 03, 2023

Major Issues Report

Form 8-K - Current report